PR

Professor Robinson

Ecofibre Limited | Non-Executive Director
Mr Robinson is a practising Endocrinologist at Sydney's Royal North Shore Hospital, is Former Dean of University of Sydney's Sydney Medical School. Professor Robinson has been the head of the Cancer Genetics Unit at the Kolling Institute of Medical Research, Royal North Shore Hospital since 1989. Since 2001, Professor Robinson has been Chairman of Hoc Mai Foundation, a major program in medical and health education and exchange with Vietnam. He is a Non-Executive Director of Cochlear Limited, Lorica and QBiotics Group Limited. He is a Board Member of the Woolcock Institute, is Chair of National Health and Medical Research Council and Chair of the Medical Benefits Review Taskforce.Prof Robinson is Chair of the Science, Technology and Medical Committee.

Companies and Roles

Company
Title
Tenure
Since
EOF
Ecofibre Limited
  • Non-Executive Director
3yrs, 4mthMar 2021
COH
Cochlear Limited
  • Non-Executive Director
7yrs, 7mthDec 2016
MYX
Mayne Pharma Group Limited
  • Non-Executive Director
9yrs, 10mthAug 2014

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
EOF
Ecofibre Limited
21/12/23196,66730,000144,750N/A
MYX
Mayne Pharma Group Limited
14/09/2331,745N/AN/AN/A
COH
Cochlear Limited
24/10/2201,185N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
EOF
Ecofibre Limited
21/12/23
Issued
166,667$0.180$30,000Issue of securities
COH
Cochlear Limited
24/10/22
Buy
102$194.863$19,876On-market trade
EOF
Ecofibre Limited
13/12/21
Buy
30,000$0.550$16,500On-market trade
EOF
Ecofibre Limited
01/12/21
Issued
144,750$0.670$96,982Issue of options
COH
Cochlear Limited
03/09/20
Buy
75$194.680$14,601On-market trade